RadteraRadtera
‹ All protocols
‹ Back to all protocols

MRI Brain With and Without Contrast

MR+ ContrastNeuro
Indications
  • Known/suspected brain tumor or metastases
  • Infection (abscess, meningitis, encephalitis)
  • Postoperative tumor follow-up
  • Suspected MS (active demyelination)
  • Cranial neuropathy
  • Pituitary/parasellar lesion (dedicated protocol preferred)
Patient prep
  • MRI safety screening
  • IV access for gadolinium
  • Renal function (eGFR) per site policy for GBCA
  • Head coil
Contrast
Agentgadolinium-based (e.g., gadobutrol, gadoterate)
RouteIV
Dose0.1 mmol/kg
TimingPost-contrast T1 in 3 planes (or 3D) after injection
Technique
  • Same positioning as non-contrast brain
  • Acquire full non-contrast set first (incl. DWI, FLAIR, SWI)
  • Post-contrast T1 axial + coronal, or 3D T1 (MPRAGE/BRAVO/TFE) for thin reconstructions
  • 3D post-contrast T1 preferred for metastasis detection
Series / Sequences
#Series / SequencePlaneWeighting / ReconThicknessNotes
1Sag T1sagittalT14-5 mmPre-contrast
2Ax DWI/ADCaxialDWI4-5 mm
3Ax T2 FSEaxialT24-5 mm
4Ax FLAIRaxialFLAIR4-5 mm
5Ax SWI/GREaxialT2*3-4 mm
6Ax T1 preaxialT14-5 mmBaseline for enhancement
7Ax T1 postaxialT1 +C4-5 mmPost-gadolinium
8Cor T1 postcoronalT1 +C4-5 mm
93D T1 post (MPRAGE)sagittal/axialT1 +C1 mmIsotropic; reformat any plane; best for mets
Key points
  • Pre-contrast T1 needed to distinguish enhancement from intrinsic T1 shortening (blood/melanin/fat).
  • For metastasis screening, isotropic 3D post-contrast T1 increases small-lesion detection.
  • Add post-contrast FLAIR for leptomeningeal disease.
  • MS: include before/after to demonstrate active (enhancing) lesions.
References
• ACR-ASNR-SPR Practice Parameter for MRI of the Brain
• Radiopaedia: MRI brain with contrast
• ACR Appropriateness Criteria: Cerebral metastases
Source: Researched — verify against your institution
Reference template — verify and adapt to your scanner, vendor and institution before clinical use. Not a substitute for clinical judgment.